Ming Ding

EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer

Jun Yao, G. Hortobagyi, L. Nie, 2017, Oncogene.

Site-specific characterization of the Asp- and Glu-ADP-ribosylated proteome

Yonghao Yu, Yonghao Yu, Ming Ding, 2013, Nature Methods.

Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma.

L. Chin, R. Deberardinis, Hailei Zhang, 2017, Cancer discovery.

Toxic PRn poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export

S. McKnight, J. Gall, Masato Kato, 2017, Proceedings of the National Academy of Sciences.

The LC Domain of hnRNPA2 Adopts Similar Conformations in Hydrogel Polymers, Liquid-like Droplets, and Nuclei

Yonghao Yu, Siheng Xiang, S. McKnight, 2015, Cell.

CAT‐2003: A novel sterol regulatory element‐binding protein inhibitor that reduces steatohepatitis, plasma lipids, and atherosclerosis in apolipoprotein E*3‐Leiden mice

Rick B. Vega, T. Kooistra, R. Kleemann, 2017, Hepatology communications.

Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling

Yonghao Yu, R. Bruick, M. Ding, 2016, Nature Cell Biology.